FBLG - Company ID 0001958777
The table below shows FibroBiologics, Inc.'s balance sheet line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash & equivalents | $4.89M | $13.98M | $9.16M |
| Short-term investments | - | - | - |
| Receivables | - | - | $300.00K |
| Inventory | - | - | - |
| Total current assets | $6.35M | $14.23M | $9.21M |
| Property, plant & equipment | $842.00K | $824.00K | $797.00K |
| Goodwill | - | - | - |
| Total assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.62M |
| $16.45M |
| $11.82M |
| Accounts payable | - | - | - |
| Total current liabilities | $1.76M | $12.73M | $9.18M |
| Long-term debt | - | - | - |
| Total liabilities | $3.46M | $13.71M | $10.57M |
| Retained earnings | -$54.16M | -$35.52M | -$24.36M |
| Total equity | $6.16M | $2.73M | $1.25M |